These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 36804505)

  • 1. Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension.
    Nawaytou H; Hills NK; Clyman RI
    Pediatr Res; 2023 Aug; 94(2):547-554. PubMed ID: 36804505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia-associated Pulmonary Hypertension.
    Gentle SJ; Travers CP; Clark M; Carlo WA; Ambalavanan N
    Am J Respir Crit Care Med; 2023 Apr; 207(7):921-928. PubMed ID: 36378949
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of patent ductus arteriosus shunt size and duration on risk of death or severe respiratory morbidity in preterm infants born in China.
    Deng Y; Zhang H; Zhao Z; Du J; Bai R; McNamara PJ
    Eur J Pediatr; 2022 Aug; 181(8):3131-3140. PubMed ID: 35838780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent Ductus Arteriosus and Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension: A Bayesian Meta-Analysis.
    Villamor E; van Westering-Kroon E; Gonzalez-Luis GE; Bartoš F; Abman SH; Huizing MJ
    JAMA Netw Open; 2023 Nov; 6(11):e2345299. PubMed ID: 38015504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patent Ductus Arteriosus and Lung Magnetic Resonance Imaging Phenotype in Moderate and Severe Bronchopulmonary Dysplasia-Pulmonary Hypertension.
    Bjorkman KR; Miles KG; Bellew LE; Schneider KA; Magness SM; Higano NS; Ollberding NJ; Hoyos Cordon X; Hirsch RM; Hysinger E; Woods JC; Critser PJ
    Am J Respir Crit Care Med; 2024 Aug; 210(3):318-328. PubMed ID: 38568735
    [No Abstract]   [Full Text] [Related]  

  • 6. Relationship between Duration of Infant Exposure to a Moderate-to-Large Patent Ductus Arteriosus Shunt and the Risk of Developing Bronchopulmonary Dysplasia or Death Before 36 Weeks.
    Clyman RI; Hills NK; Liebowitz M; Johng S
    Am J Perinatol; 2020 Jan; 37(2):216-223. PubMed ID: 31600791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial.
    Potsiurko S; Dobryanskyy D; Sekretar L
    BMC Pediatr; 2021 Jun; 21(1):286. PubMed ID: 34147090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia.
    Clyman RI; Hills NK; Cambonie G; Debillon T; Ligi I; Gascoin G; Patkai J; Beuchee A; Favrais G; Durrmeyer X; Flamant C; Rozé JC
    Pediatr Res; 2022 Feb; 91(3):652-658. PubMed ID: 33790415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Nonsteroidal Anti-inflammatory Drug Treatment vs No Treatment for Patent Ductus Arteriosus in Preterm Infants.
    Slaughter JL; Reagan PB; Newman TB; Klebanoff MA
    JAMA Pediatr; 2017 Mar; 171(3):e164354. PubMed ID: 28046188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors that affect the degree of bronchopulmonary dysplasia in very preterm infants: a 5-year retrospective study.
    Yang T; Shen Q; Wang S; Dong T; Liang L; Xu F; He Y; Li C; Luo F; Liang J; Tang C; Yang J
    BMC Pediatr; 2022 Apr; 22(1):200. PubMed ID: 35413820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patent Ductus Arteriosus and the Effects of Its Late Closure in Preterm Infants with Severe Bronchopulmonary Dysplasia.
    Ansems SM; Kirpalani H; Mercer-Rosa L; Wang Y; Hopper RK; Fraga MV; Jensen EA
    Neonatology; 2019; 116(3):236-243. PubMed ID: 31269508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diseases associated with prematurity in correlation with N-terminal pro-brain natriuretic peptide levels during the early postnatal life.
    Fritz AS; Keller T; Kribs A; Hünseler C
    Eur J Pediatr; 2023 Jul; 182(7):3075-3082. PubMed ID: 37072630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol: baby-OSCAR trial: Outcome after Selective early treatment for Closure of patent ductus ARteriosus in preterm babies, a multicentre, masked, randomised placebo-controlled parallel group trial.
    Gupta S; Juszczak E; Hardy P; Subhedar N; Wyllie J; Kelsall W; Sinha S; Johnson S; Roberts T; Hutchison E; Pepperell J; Linsell L; Bell JL; Stanbury K; Laube M; Edwards C; Field D;
    BMC Pediatr; 2021 Feb; 21(1):100. PubMed ID: 33637074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors and prognosis of bronchopulmonary dysplasia associated pulmonary hypertension in preterm infants].
    Chen C; Huang P; Lin BC; Chen XY; Zhao J; Sun HY; Yu YL; Chen S; Qiu XM; Yang CZ
    Zhonghua Er Ke Za Zhi; 2020 Sep; 58(9):747-752. PubMed ID: 32872715
    [No Abstract]   [Full Text] [Related]  

  • 15. Duration of significant patent ductus arteriosus and bronchopulmonary dysplasia in extremely preterm infants.
    Mirza H; Garcia J; McKinley G; Hubbard L; Sensing W; Schneider J; Oh W; Wadhawan R
    J Perinatol; 2019 Dec; 39(12):1648-1655. PubMed ID: 31554913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical features and prognosis of bronchopulmonary dysplasia complicated by pulmonary hypertension in preterm infants].
    Wang CH; Shi LP; Ma XL; DU LZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2018 Nov; 20(11):893-896. PubMed ID: 30477618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Atrial Left-to-Right Shunt on Pulmonary Hypertension in Preterm Infants with Moderate or Severe Bronchopulmonary Dysplasia.
    Choi EK; Jung YH; Kim HS; Shin SH; Choi CW; Kim EK; Kim BI; Choi JH
    Pediatr Neonatol; 2015 Oct; 56(5):317-23. PubMed ID: 26328892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indomethacin for symptomatic patent ductus arteriosus in preterm infants.
    Evans P; O'Reilly D; Flyer JN; Soll R; Mitra S
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013133. PubMed ID: 33448032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patent ductus arteriosus (PDA) and pulmonary morbidity: can early targeted pharmacologic PDA treatment decrease the risk of bronchopulmonary dysplasia?
    Clyman RI; Hills NK
    Semin Perinatol; 2023 Mar; 47(2):151718. PubMed ID: 36882361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prolonged tracheal intubation on the association between patent ductus arteriosus and bronchopulmonary dysplasia (grades 2 and 3).
    Clyman RI; Hills NK
    J Perinatol; 2020 Sep; 40(9):1358-1365. PubMed ID: 32669644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.